Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Clinical trial of Tinidazole (Fasigyn) in acute and chronic intestinal amoebiasis

Lim JK

Tinidazole (Fasigyn), a new drug which is active in vitro and in vivo against Entamoeba histolytica, was used in 30 Korean patients with acute and chronic intestinal amoebiasis. In aute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?

Jeon HK, Kim GH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Low - dose Clarithromycin Triple Therapy and tinidazole - containing Triple Therapy forfor Helicobacter pylori Eradication

Choi IJ, Jung HC, Choi KW, Kim JH, Ahn DS, Yang US, Rew JS, Lee SI, Rhee JC, Chung IS, Chung JM, Hong WS

  • KMID: 2084981
  • Korean J Gastroenterol.
  • 2001 May;37(5):336-344.
BACKGROUND/AIMS: Proton pump inhibitor-based triple therapies are recommended as the first-line treatment for Helicobacter pylori (H. pylori) eradication. However, the effect of lowering clarithromycin dose and the efficacy of nitroimidazole-containing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug-resistant Profiles of Clinical Isolates of Gardnerella vaginalis on Columbia Agar Base Supplemented with Human Erythrocyte Lysate and Horse Serum

Yang NW, Lim Y, Sin SH

  • KMID: 1808164
  • Infect Chemother.
  • 2003 Apr;35(2):86-90.
BACKGROUND: To the best of our knowledge, there has been no any report on the antibiotic susceptibility profile of Gardnerella vaginalis, determined in domestic area by the agar dilution method....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
“Targeted” prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy

Singh P, Kumar A, Yadav S, Prakash L, Nayak B, Kumar R, Kapil A, Dogra PN

PURPOSE: To assess the prevalence of fluoroquinolone resistance among patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy and the impact of rectal swab culture-directed antibiotic prophylaxis on postbiopsy infectious complications. MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Parasitic amebae in Korea

Soh CT

This review dealt with biology, host-parasite relationship, symptomatology, epidemiology, diagnosis, treatment of Entamoeba histolytica infection and free livng amoeba.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Combination of Anticancer Agents and Nitroimidazoles on the Survival of Human Hepatocellular Carcinoma Cells under Hypoxic Conditions

Lim SH, Lee JY, Park SH, Kim YH, Suh HS, Park JB, Lee J

PURPOSE: In a previous study, we have shown that anticancer agents inhibiting topoisomerases improve survival of tumor cells under hypoxic condition. In the present study, we evaluated whether and how...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Resistant Patterns of Clinical Isolates of Trichomonas vaginalis against Antiprotozoal Agents under A Newly Devised Anaerobic Box

Yang NW, Lim Y, Shin SH, Lee KK, Ra YJ, Jang HJ

  • KMID: 2248560
  • Korean J Infect Dis.
  • 2000 Feb;32(1):41-48.
BACKGROUND: We thought that nitroimidazoles including metronidazole had been overused empirically for treatment of trichomoniasis in Korea. But there were not any reports about in vitro-drug susceptibility and distribution of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?

Gong EJ, Yun SC, Jung HY, Lim H, Choi KS, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH

Proton pump inhibitor (PPI)-based triple therapy consisting of PPI, amoxicillin, and clarithromycin, is the recommended first-line treatment for Helicobacter pylori infection. However, the eradication rate of triple therapy has declined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr